Theravance Biopharma
TBPH
TBPH
113 hedge funds and large institutions have $653M invested in Theravance Biopharma in 2023 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 37 increasing their positions, 43 reducing their positions, and 16 closing their positions.
Holders
113
Holders Change
-6
Holders Change %
-5.04%
% of All Funds
1.81%
Holding in Top 10
4
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-20%
% of All Funds
0.06%
New
10
Increased
37
Reduced
43
Closed
16
Calls
$2.43M
Puts
$947K
Net Calls
+$1.49M
Net Calls Change
-$10.1M
Top Buyers
Top Sellers
| 1 |
BG
1
Baupost Group
Boston,
Massachusetts
|
$113M |
| 2 |
2
Fidelity Investments
Boston,
Massachusetts
|
$18.6M |
| 3 |
3
Two Sigma Investments
New York
|
$3.87M |
| 4 |
4
D.E. Shaw & Co
New York
|
$11M |
| 5 |
5
Millennium Management
New York
|
$1.52M |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
126
Verition Fund Management
Greenwich,
Connecticut
| – | – | -11,261 | Closed |
|
|
MLICM
127
Metropolitan Life Insurance Company (MetLife)
New York
| – | – | -4,078 | Closed |
|
|
PMEF
128
Point72 Middle East FZE
Dubai,
United Arab Emirates
| – | – | -3,649 | Closed |
|
|
LC
129
Lindbrook Capital
Calabasas,
California
| – | – | -132 | Closed |
|
130
Simplex Trading
Chicago,
Illinois
| – | – | – | – |
|
131
Walleye Trading
New York
| – | – | – | – |
|
132
First Manhattan
New York
| – | – | – | – |
|
|
CFGS
133
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
134
Walleye Capital
New York
| – | – | – | – |
|